These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 955741)

  • 1. Design of experiments using the microcytotoxicity assay.
    Brown JP; van Belle G; Hellström I
    Int J Cancer; 1976 Aug; 18(2):230-5. PubMed ID: 955741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Position-dependent cell survival and the microcytotoxicity assay.
    Chalmers PJ; Pullen GR; Nind AP; Nairn RC
    J Immunol Methods; 1982; 51(1):81-8. PubMed ID: 7108230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in sensitivity of the microcytotoxicity assay by T cell growth factor (IL-2)-containing preparations.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1984; 30(1):43-9. PubMed ID: 6609090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity to Friend virus-induced leukemia. I. Modification of 125IUdR release cytotoxicity assay for use with suspension target cells.
    Ting C-C ; Bushar GS; Rodrigues D; Herberman RB
    J Immunol; 1975 Nov; 115(5):1351-6. PubMed ID: 170343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A computer-interfaced photometer and systematic spacing of duplicates to control within-plate enzyme-immunoassay variation.
    Stemshorn BW; Buckley DJ; St Amour G; Lin CS; Duncan JR
    J Immunol Methods; 1983 Jul; 61(3):367-75. PubMed ID: 6348166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paul Ichiro Terasaki (1929-2016): Inventor of the microcytotoxicity assay and pioneer tissue typer.
    Bodmer WF
    HLA; 2016 May; 87(5):333-7. PubMed ID: 27101942
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitigation of microtiter plate positioning effects using a block randomization scheme.
    Roselle C; Verch T; Shank-Retzlaff M
    Anal Bioanal Chem; 2016 Jun; 408(15):3969-79. PubMed ID: 27116421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of cell-mediated immunity to malignant mesothelioma by microcytotoxicity tests.
    Embleton MJ; Wagner JC; Wagner MM; Jones JS; Sheers G; Oldham PD; Baldwin RW
    Int J Cancer; 1976 May; 17(5):597-601. PubMed ID: 1270175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcytotoxicity assay for platelet antibodies using fresh and frozen fluorescein-labeled target platelets.
    Graddick SL; Lazarchick J; Hall SA
    Diagn Clin Immunol; 1987; 5(2):82-5. PubMed ID: 3304697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 51Cr release assay of antibody-dependent cell-mediated cytotoxicity (ADCC).
    Nelson DL; Kurman CC; Serbousek DE
    Curr Protoc Immunol; 2001 May; Chapter 7():Unit 7.27. PubMed ID: 18432838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of sensitive complement-dependent microcytotoxicity serological methods.
    Richiardi P; Belvedere M; Borelli I; Curtoni ES
    Haematologica; 1977 Oct; 62(5):479-89. PubMed ID: 412735
    [No Abstract]   [Full Text] [Related]  

  • 13. Specificities in natural cell-mediated cytotoxicity by the cross-competition assay.
    Takasugi M; Koide D; Ramseyer A
    Int J Cancer; 1977 Mar; 19(3):291-7. PubMed ID: 300365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specificity of the microcytotoxicity assay for cell-mediated immunity in human bladder cancer.
    Vilien M; Wolf H
    J Urol; 1978 Mar; 119(3):338-42. PubMed ID: 273706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial adenine uptake as an assay for cell- or complement-mediated cytotoxicity.
    DeBono DP; Macintyre DE; White DJ; Gordon JL
    Immunology; 1977 Feb; 32(2):221-6. PubMed ID: 844895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the microcytotoxicity test. I. Evidence that the effects of normal lymphoid cells on tumour cell growth in microtest plates may be caused by non-immunological modifications of the culture medium.
    Brooks CG; Rees RC; Baldwin RW
    Int J Cancer; 1976 Dec; 18(6):778-86. PubMed ID: 186418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Br J Cancer; 1977 Jun; 35(6):834-43. PubMed ID: 194618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-T cell killing of mammary tumor cells by spleen cells: secretion of antibody and recruitment of cells.
    Blair PB; Lane MA
    J Immunol; 1975 Jul; 115(1):184-9. PubMed ID: 168254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test.
    Shiku H; Bean MA; Old LJ; Oettgen HF
    J Natl Cancer Inst; 1975 Feb; 54(2):415-25. PubMed ID: 1113324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural cell-mediated cytotoxicity: a micro assay suitable for clinical tests.
    Tentori L; Alvino E; Fuggetta MP; D'Atri S; Giganti MG; Caliendo R; Bonmassar E
    Chemioterapia; 1985 Dec; 4(6):471-4. PubMed ID: 3868428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.